HeartCycle

HeartCycle consortium, comprising 18 research, academic, industrial and medical organizations from 9 different European countries and China, will work to improve the quality of life for coronary heart disease and heart failure patients by monitoring their condition and involving them in the daily management of their disease. The consortium will also develop mechanisms to automatically report relevant monitoring data back to clinicians so that they can prescribe personalized therapies and lifestyle recommendations.

Compliance to prescribed therapies is a common problem associated with long-term treatment, and will become even more problematic as the European population ages and chronic disease becomes more prevalent. There is strong evidence that increasing the level of patient compliance may have a far greater impact on the health of the population than improvements in specific medical treatments. The HeartCycle project intends to tackle this in two ways.

Firstly by creating a 'patient loop' that gives patients continuous feedback on their state of health, their progress towards achieving health status milestones, plus motivational tips and suggestions for a healthy lifestyle and diet. In the course of the project it will be investigated whether such measures will improve the adherence to prescribed therapies. Monitoring each patient's condition will be achieved using a combination of unobtrusive bio-sensors built into the patient's clothing or bed sheets and home appliances such as weighing scales and blood pressure monitors. Sensing of an individual patient's physical exertion, body orientation and ambient environment will provide additional information so that the system can put the monitoring data into context.

Secondly by enabling a 'professional loop' in which relevant data on a patient’s state of health and therapy adherence is automatically communicated to a hospital information system. This professional loop will allow doctors to monitor each patient's condition and therapy response in order to create optimized individual care plans, as well as allowing them to identify deterioration or sudden cardiac events that require immediate remedial action.

For further information, please visit:
http://www.heartcycle.eu

Project co-ordinator:
Philips Research

Partners:

  • Aristotle University of Thessaloniki (Greece);
  • Clothing Plus Oy (Finland);
  • CSEM Centre Suisse D'electronique Et De Microtechnique Sa (Switzerland);
  • Empirica Gesellschaft für Kommunikations und Technologieforschung mbH (Germany);
  • Faculdade Ciencias e Tecnologia da Universidade de Coimbra (Portugal);
  • Fundación Vodafone España (Spain);
  • Hospital Universitario Clínico San Carlos (Spain);
  • Instituto de Aplicaciones de las Tecnologías de la Información y de las Comunicaciones Avanzadas (Spain);
  • Medtronic Ibérica SA (Spain);
  • Philips Electronics Nederland B.V. (The Netherlands);
  • Philips Research (Germany);
  • Politecnico Di Milano - Dipartimento di Bioingegneria (Italy);
  • Rheinisch Westfälische Technische Hochschule (Germany);
  • T-Systems ITC Iberia SA (Spain);
  • Universidad Politécnica de Madrid (Spain);
  • Chinese University of Hong Kong (China);
  • University of Hull (United Kingdom);
  • Valtion Teknillinen Tutkimuskeskus (Finland).

Timetable: from 03/2008 – to 02/2012

Total cost: € 21.985.444

EC funding: € 14.100.000

Programme Acronym: FP7-ICT

Subprogramme Area: Personal health systems for monitoring and point-of-care diagnostics

Contract type: Collaborative project (generic)


Related news articles:

Most Popular Now

Novartis and Microsoft Announce Collabor…

Novartis announced an important step in reimagining medicine by founding the Novartis AI innovation lab and by selecting Microsoft as its strategic AI and data-science partner for this effort. The...

Bayer Inks Deals with Eleven Startups un…

Bayer announced today that the company has signed collaboration agreements with eleven digital health startups. As part of the program, Bayer will support these startup companies aiming for longer-term collaborations...

Almirall Takes a Leap into Dermatology D…

Almirall, S.A. (ALM) has launched its first call for innovation to start-ups focused on dermatology digital health. This initiative is the first step in the creation of an accelerator programme...

Guerbet and IBM Watson Health Announce a…

Guerbet, a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, announced that it has signed a new agreement with IBM Watson Health to co-develop and...

Health Tech Marketing and PR Agency Incr…

Highland Marketing, a full service agency for health techmarketing, PR and communications, has appointed Tia Dissanayake to a new account executive role,in which she will support the team withher life...

Up-Close and Personal with Neuronal Netw…

How our brain cells, or neurons, use electrical signals to communicate and coordinate for higher brain function is one of the biggest questions in all of science. For decades, researchers...

Patients Say Ask before Using Medical Re…

With electronic medical records creating an ideal source of data to inform quality care and new discovery, a key question emerges: How much say should patients have in how their...

Secret-Shopper-Style Study Shows Online …

Web-based and digital-app services that offer oral contraception appear to be overall safe and efficient, according to the findings of a secret-shopper-style study conducted by researchers at Harvard Medical School...

Virtual Medical Visits Get Wary Welcome …

The technology is there. The funding is nearly there. The health providers are getting there. But a new US poll suggests that people over 50 aren't quite ready to fully...

Philips and Spencer Health Solutions Exp…

Building on their successful partnership providing medication adherence solutions to high-acuity patients in the U.S. Royal Philips (NYSE:PHG, AEX:PHIA), a global leader in health technology, and Spencer Health Solutions announced...